Related Experiment Video
Updated: May 6, 2026
Fluorescence Anisotropy as a Tool to Study Protein-protein Interactions
Published on: October 21, 2016
A fluorescence anisotropy-based Myt1 kinase binding assay
Alexander Rohe1, Claudia Henze, Frank Erdmann
11 Department of Medicinal Chemistry, Martin Luther University Halle-Wittenberg , Halle, Germany .
Abstract:
Abstract The human Myt1 kinase is a regulator of Cdk1/CycB and, hence, important for the G2/M transition in the cell cycle. It may act as a target for drug development, but suitable assay systems for assessing potential inhibitors are lacking so far. Herein, we describe the rational development of a fluorescence anisotropy-based kinase binding assay. A suitable fluoroprobe based on the tyrosine kinase inhibitor dasatinib was synthesized and tested with Myt1 and several other kinases for control purposes. The probe acted as expected in terms of specificity and reversibility, and a Myt1 assay was set up. Notwithstanding the moderate Kd of the starting compound dasatinib before chemical modification, satisfying Z' factors >0.5 were achieved. A validation with known kinase inhibitors demonstrated the applicability of the assay and led to a reliable ranking of the tested active compounds.
Insights
Researchers developed a novel fluorescence anisotropy assay to study Myt1 kinase, a key cell cycle regulator. This assay enables the screening of potential Myt1 inhibitors for drug development, offering a reliable method for ranking compound activity.
Area of Science:
- Biochemistry
- Cell Biology
- Drug Discovery
Background:
- Human Myt1 kinase regulates the cell cycle's G2/M transition via Cdk1/CycB.
- Myt1 kinase is a potential drug development target, but lacks suitable assay systems.
- Assessing Myt1 kinase inhibitors requires robust and reliable screening methods.
Purpose of the Study:
- To rationally develop a fluorescence anisotropy-based kinase binding assay for human Myt1.
- To establish a reliable system for evaluating Myt1 kinase inhibitors.
- To facilitate drug discovery efforts targeting Myt1 kinase.
Main Methods:
- Synthesis of a fluoroprobe based on the tyrosine kinase inhibitor dasatinib.
- Development of a fluorescence anisotropy assay using the synthesized fluoroprobe.
- Testing the assay's specificity, reversibility, and performance with Myt1 and control kinases.
Main Results:
- A specific and reversible fluoroprobe for Myt1 kinase was successfully synthesized.
- A robust Myt1 kinase binding assay with Z' factors >0.5 was established.
- The assay demonstrated applicability and provided a reliable ranking of known kinase inhibitors.
Conclusions:
- The developed fluorescence anisotropy assay is a valuable tool for Myt1 kinase research.
- This assay system supports the identification and characterization of Myt1 inhibitors.
- The assay facilitates drug discovery targeting the cell cycle regulator Myt1 kinase.
